Swallowable AI Capsule Endoscope PillScope Gets FDA Approval: GI Exam Without Anesthesia
PillScope capsule endoscope with built-in AI analysis automatically identifies polyps and early lesions during its GI journey, completing the exam in just 8 hours.
Swallowable AI Capsule Endoscope PillScope Gets FDA Approval: GI Exam Without Anesthesia
Israeli medical device company Given Imaging announced on April 6 that its next-generation AI capsule endoscope PillScope has received FDA approval. After a patient swallows the pill-sized capsule, it automatically captures over 100,000 high-resolution images during its 8- to 12-hour journey through the digestive tract, using an onboard AI chip to flag suspected lesion areas in real time.
PillScope's built-in AI model, trained on over 5 million annotated endoscopic images, achieves a 97.2% polyp detection rate and 94.8% sensitivity for early GI cancers. Unlike traditional capsule endoscopes, PillScope can generate a report immediately after the exam ends, eliminating the need for physicians to review images frame by frame.
Each PillScope capsule is priced at $1,200, comparable to a traditional endoscopy, but requires no anesthesia or hospitalization.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.